US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist
  • 35.630
  • +0.040+0.11%
Close Dec 20 16:00 ET
  • 35.500
  • -0.130-0.36%
Post 20:01 ET
5.63BMarket Cap-14.60P/E (TTM)

Ionis Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-7.21%133.81M
19.55%225.25M
-8.45%119.5M
34.10%787.65M
113.65%324.51M
-9.74%144.21M
40.82%188.41M
-8.03%130.52M
-27.53%587.37M
-65.48%151.89M
Operating revenue
-7.21%133.81M
19.55%225.25M
-8.45%119.5M
34.10%787.65M
113.65%324.51M
-9.74%144.21M
40.82%188.41M
-8.03%130.52M
-27.53%587.37M
-65.48%151.89M
Cost of revenue
-51.12%1.07M
64.13%4.16M
60.16%2.15M
-35.30%9.13M
-16.93%3.06M
44.62%2.19M
-46.53%2.54M
-67.79%1.34M
30.20%14.12M
65.59%3.69M
Gross profit
-6.53%132.74M
18.94%221.09M
-9.16%117.35M
35.81%778.51M
116.89%321.44M
-10.26%142.02M
44.04%185.87M
-6.22%129.18M
-28.31%573.25M
-66.15%148.2M
Operating expense
-1.39%281.36M
4.02%287.18M
9.67%266.86M
15.13%1.13B
-8.03%327.56M
31.25%285.33M
28.67%276.07M
24.62%243.33M
20.76%983.45M
63.25%356.17M
Selling and administrative expenses
-12.00%61.6M
41.11%65.11M
15.66%52.64M
54.76%232.6M
48.23%71M
103.49%70M
36.51%46.14M
33.37%45.52M
-12.05%150.3M
24.09%47.9M
-General and administrative expense
-12.00%61.6M
----
15.66%52.64M
54.76%232.6M
48.23%71M
103.49%70M
----
33.37%45.52M
-12.05%150.3M
24.09%47.9M
Research and development costs
2.06%219.76M
-3.42%222.06M
8.29%214.22M
7.98%899.63M
-16.78%256.56M
17.67%215.33M
27.20%229.93M
22.77%197.81M
29.48%833.15M
71.67%308.27M
Operating profit
-3.70%-148.62M
26.72%-66.09M
-30.98%-149.51M
13.77%-353.71M
97.06%-6.11M
-142.34%-143.31M
-5.48%-90.2M
-98.50%-114.15M
-2,683.07%-410.2M
-194.70%-207.97M
Net non-operating interest income expense
-3.43%-22.73M
-14.24%-22.79M
-29.12%-22.11M
-906.14%-81.5M
-1,220.53%-22.45M
-946.62%-21.98M
-849.81%-19.95M
-706.93%-17.12M
12.90%-8.1M
22.73%-1.7M
Non-operating interest income
----
----
--49K
----
----
----
----
----
----
----
Non-operating interest expense
4.19%21.23M
14.24%22.79M
29.93%20.56M
2,599.89%75.6M
5,112.25%20.85M
2,447.38%20.38M
2,393.25%19.95M
1,824.94%15.82M
-36.36%2.8M
-50.00%400K
Total other finance cost
-6.25%1.5M
----
23.08%1.6M
11.32%5.9M
23.08%1.6M
23.08%1.6M
----
0.00%1.3M
8.16%5.3M
-7.14%1.3M
Other net income (expense)
11.50%27.25M
-30.64%22.68M
57.65%28.9M
-36.87%101.22M
-84.43%25.76M
67.57%24.44M
314.65%32.69M
512.33%18.33M
3,298.24%160.33M
2,091.28%165.42M
Gain on sale of security
23.26%27.11M
2.58%22.07M
58.13%28.62M
-48.11%86.97M
-84.61%25.36M
122.79%21.99M
833.13%21.51M
490.72%18.1M
731.90%167.6M
2,245.16%164.77M
Other non- operating income (expenses)
-94.20%142K
-94.55%610K
20.43%277K
295.99%14.26M
-38.52%399K
-48.08%2.45M
190.94%11.18M
22.99%230K
25.47%-7.27M
236.06%649K
Income before tax
-2.34%-144.1M
14.52%-66.2M
-26.37%-142.73M
-29.45%-333.97M
93.76%-2.77M
-201.46%-140.81M
24.72%-77.45M
-76.28%-112.94M
-785.09%-257.99M
-119.71%-44.33M
Income tax
-154.85%-3.62M
-99.18%64K
-99.34%75K
175.38%32.32M
-19.80%6.5M
2,232.86%6.6M
246.99%7.84M
940.22%11.38M
2,230.13%11.74M
2,573.27%8.1M
Net income
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
-35.80%-366.29M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-843.18%-269.72M
-123.34%-52.43M
Net income continuous Operations
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
-35.80%-366.29M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-843.18%-269.72M
-123.34%-52.43M
Minority interest income
Net income attributable to the parent company
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
-35.80%-366.29M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-843.18%-269.72M
-123.34%-52.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
-35.80%-366.29M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-843.18%-269.72M
-123.34%-52.43M
Basic earnings per share
7.77%-0.95
25.00%-0.45
-12.64%-0.98
-34.74%-2.56
83.78%-0.06
-212.12%-1.03
18.92%-0.6
-89.13%-0.87
-850.00%-1.9
-123.27%-0.37
Diluted earnings per share
7.77%-0.95
25.00%-0.45
-12.64%-0.98
-34.74%-2.56
83.78%-0.06
-212.12%-1.03
18.92%-0.6
-89.13%-0.87
-850.00%-1.9
-126.24%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -7.21%133.81M19.55%225.25M-8.45%119.5M34.10%787.65M113.65%324.51M-9.74%144.21M40.82%188.41M-8.03%130.52M-27.53%587.37M-65.48%151.89M
Operating revenue -7.21%133.81M19.55%225.25M-8.45%119.5M34.10%787.65M113.65%324.51M-9.74%144.21M40.82%188.41M-8.03%130.52M-27.53%587.37M-65.48%151.89M
Cost of revenue -51.12%1.07M64.13%4.16M60.16%2.15M-35.30%9.13M-16.93%3.06M44.62%2.19M-46.53%2.54M-67.79%1.34M30.20%14.12M65.59%3.69M
Gross profit -6.53%132.74M18.94%221.09M-9.16%117.35M35.81%778.51M116.89%321.44M-10.26%142.02M44.04%185.87M-6.22%129.18M-28.31%573.25M-66.15%148.2M
Operating expense -1.39%281.36M4.02%287.18M9.67%266.86M15.13%1.13B-8.03%327.56M31.25%285.33M28.67%276.07M24.62%243.33M20.76%983.45M63.25%356.17M
Selling and administrative expenses -12.00%61.6M41.11%65.11M15.66%52.64M54.76%232.6M48.23%71M103.49%70M36.51%46.14M33.37%45.52M-12.05%150.3M24.09%47.9M
-General and administrative expense -12.00%61.6M----15.66%52.64M54.76%232.6M48.23%71M103.49%70M----33.37%45.52M-12.05%150.3M24.09%47.9M
Research and development costs 2.06%219.76M-3.42%222.06M8.29%214.22M7.98%899.63M-16.78%256.56M17.67%215.33M27.20%229.93M22.77%197.81M29.48%833.15M71.67%308.27M
Operating profit -3.70%-148.62M26.72%-66.09M-30.98%-149.51M13.77%-353.71M97.06%-6.11M-142.34%-143.31M-5.48%-90.2M-98.50%-114.15M-2,683.07%-410.2M-194.70%-207.97M
Net non-operating interest income expense -3.43%-22.73M-14.24%-22.79M-29.12%-22.11M-906.14%-81.5M-1,220.53%-22.45M-946.62%-21.98M-849.81%-19.95M-706.93%-17.12M12.90%-8.1M22.73%-1.7M
Non-operating interest income ----------49K----------------------------
Non-operating interest expense 4.19%21.23M14.24%22.79M29.93%20.56M2,599.89%75.6M5,112.25%20.85M2,447.38%20.38M2,393.25%19.95M1,824.94%15.82M-36.36%2.8M-50.00%400K
Total other finance cost -6.25%1.5M----23.08%1.6M11.32%5.9M23.08%1.6M23.08%1.6M----0.00%1.3M8.16%5.3M-7.14%1.3M
Other net income (expense) 11.50%27.25M-30.64%22.68M57.65%28.9M-36.87%101.22M-84.43%25.76M67.57%24.44M314.65%32.69M512.33%18.33M3,298.24%160.33M2,091.28%165.42M
Gain on sale of security 23.26%27.11M2.58%22.07M58.13%28.62M-48.11%86.97M-84.61%25.36M122.79%21.99M833.13%21.51M490.72%18.1M731.90%167.6M2,245.16%164.77M
Other non- operating income (expenses) -94.20%142K-94.55%610K20.43%277K295.99%14.26M-38.52%399K-48.08%2.45M190.94%11.18M22.99%230K25.47%-7.27M236.06%649K
Income before tax -2.34%-144.1M14.52%-66.2M-26.37%-142.73M-29.45%-333.97M93.76%-2.77M-201.46%-140.81M24.72%-77.45M-76.28%-112.94M-785.09%-257.99M-119.71%-44.33M
Income tax -154.85%-3.62M-99.18%64K-99.34%75K175.38%32.32M-19.80%6.5M2,232.86%6.6M246.99%7.84M940.22%11.38M2,230.13%11.74M2,573.27%8.1M
Net income 4.70%-140.48M22.31%-66.27M-14.86%-142.8M-35.80%-366.29M82.33%-9.26M-213.69%-147.41M18.88%-85.29M-90.78%-124.32M-843.18%-269.72M-123.34%-52.43M
Net income continuous Operations 4.70%-140.48M22.31%-66.27M-14.86%-142.8M-35.80%-366.29M82.33%-9.26M-213.69%-147.41M18.88%-85.29M-90.78%-124.32M-843.18%-269.72M-123.34%-52.43M
Minority interest income
Net income attributable to the parent company 4.70%-140.48M22.31%-66.27M-14.86%-142.8M-35.80%-366.29M82.33%-9.26M-213.69%-147.41M18.88%-85.29M-90.78%-124.32M-843.18%-269.72M-123.34%-52.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.70%-140.48M22.31%-66.27M-14.86%-142.8M-35.80%-366.29M82.33%-9.26M-213.69%-147.41M18.88%-85.29M-90.78%-124.32M-843.18%-269.72M-123.34%-52.43M
Basic earnings per share 7.77%-0.9525.00%-0.45-12.64%-0.98-34.74%-2.5683.78%-0.06-212.12%-1.0318.92%-0.6-89.13%-0.87-850.00%-1.9-123.27%-0.37
Diluted earnings per share 7.77%-0.9525.00%-0.45-12.64%-0.98-34.74%-2.5683.78%-0.06-212.12%-1.0318.92%-0.6-89.13%-0.87-850.00%-1.9-126.24%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.